BRD9 status is a major contributor for cysteine metabolic remodeling through MST and EAAT3 modulation in malignant melanoma

Ana Hipólito(Instituto Português de Oncologia de Coimbra Francisco Gentil), Jacinta Serpa(Instituto Português de Oncologia de Coimbra Francisco Gentil)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
December 7, 2023
10.1016/j.bbadis.2023.166983
Cited by 5

Related Papers

Functional redundancy of the Notch pathway in ovarian cancer cell lines
|Oncology Letters|2016|9
H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine
|Antioxidants|2023|6
Glucagon and Glucose Availability Influence Metabolic Heterogeneity and Malignancy in Pancreatic Neuroendocrine Tumour (pNET) Cells: Novel Routes for Therapeutic Targeting
|Molecules|2025|1